Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aims of this study are to compare the antipsychotic and adverse events of quetiapine, an atypical antipsychotic drug, to haloperidol, a standard treatment for primary psychotic disorder, in individuals with MAP.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chulalongkorn University
• Collaborators: National Research Council of Thailand; Thanyarak Institute
• Treatments: Cinnarizine; Diazepam; Haloperidol; Haloperidol decanoate; Methamphetamine; Quetiapine Fumarate; Thiamine; Vitamin B Complex; Vitamins

Criteria

Inclusion Criteria:

• Having a psychotic episode with current use of methamphetamine

• Positive urine toxicology test for methamphetamine on the first day of hospitalization

Exclusion Criteria:

• Using other illegal substances

• Having a history of primary psychotic disorders or using antipsychotic agents

• Having a chronic medical disease, e.g. essential hypertension, diabetes, epilepsy, stroke